GLP-1 Medication Linked to Decline in Exercise Habits

Patients prescribed GLP-1 receptor agonists, such as semaglutide and tirzepatide, are showing a significant decline in physical activity levels, according to research presented at the Endocrine Society’s ENDO 2024 conference. While these medications effectively reduce body weight, the loss often includes lean muscle mass, making structured strength training essential to maintaining metabolic health and physical function during treatment.

Why GLP-1 Users Exercise Less

Recent data analyzed by researchers at the University of Florida indicates that individuals on GLP-1 medications report lower levels of physical activity compared to those not using the drugs. The study, which observed patient behavior through digital health tracking, suggests that the rapid reduction in appetite and caloric intake may inadvertently lead to a decrease in energy expenditure.

Clinicians note that because these medications mimic hormones that signal satiety, patients may experience fatigue or a lack of motivation to engage in vigorous physical activity. This trend is concerning because weight loss achieved through medication alone often results in a "sarcopenic" effect, where the body sheds both fat and muscle tissue.

The Risk of Muscle Loss During Weight Loss

When a patient loses weight rapidly, the body often prioritizes breaking down muscle tissue for energy. According to the American College of Sports Medicine, preserving muscle mass is vital for long-term weight maintenance and metabolic health. Muscle tissue is metabolically active; having more of it helps the body burn more calories at rest.

Without resistance training, patients on GLP-1s may reach their goal weight but find themselves with a lower percentage of lean body mass than when they started. This can lead to decreased strength, lower bone density, and a higher likelihood of weight regain once the medication is stopped.

Essential Strength Exercises for GLP-1 Patients

To counter muscle loss, medical professionals recommend incorporating resistance training at least twice a week. Experts, including those cited by The Times, emphasize movements that target large muscle groups to maximize efficiency.

• Squats: These engage the quadriceps, hamstrings, and glutes, which are the largest muscle groups in the body.
• Push-ups: A foundational movement for chest, shoulder, and tricep strength.
• Lunges: These improve lower-body stability and unilateral strength.
• Planks: Essential for core stability and preventing lower back pain.
• Rows: Using resistance bands or dumbbells helps counteract the postural effects of sedentary desk work.

Integrating Activity into Daily Life

Maintaining physical activity while on GLP-1 therapy does not require hours in the gym. The Centers for Disease Control and Prevention (CDC) recommends 150 minutes of moderate-intensity activity per week. For those on weight-loss medications, the focus should remain on consistency rather than intensity.

Patients are encouraged to track their progress using wearable devices to ensure they are meeting activity thresholds. If fatigue is a barrier, breaking exercise into 10-minute segments throughout the day can be as effective as one long session. Consulting with a physician or a registered dietitian before starting a new exercise regimen remains the standard of care, particularly for patients managing comorbid conditions like type 2 diabetes or cardiovascular disease.

Key Considerations for Patients

• Prioritize Protein: Consuming adequate protein—typically 1.2 to 1.5 grams per kilogram of body weight—supports muscle retention during a caloric deficit.
• Monitor Energy Levels: If exercise feels impossible due to extreme fatigue, speak with a prescribing doctor about adjusting the medication dosage or timing.
• Focus on Function: Strength training should aim to improve daily functional movements, such as carrying groceries or climbing stairs, which promotes long-term mobility.